LHC Group (LHCG) Receives a Buy from Cantor Fitzgerald


Cantor Fitzgerald analyst Joseph France maintained a Buy rating on LHC Group (NASDAQ: LHCG) today and set a price target of $117. The company’s shares opened today at $91.43.

France observed:

“We have an Overweight rating and 12-month price target of $117 on LHCG shares. We believe that LHCG is well-positioned to capitalize on a consolidating industry with its scale and attractive business model, and that the shift to value-based reimbursement and aging demographics will drive faster earnings growth. In addition, we believe there is an opportunity to improve operating margins, and compete in its markets more effectively by leveraging its recent merger with Almost Family.”

According to TipRanks.com, France is a 5-star analyst with an average return of 10.1% and a 59.7% success rate. France covers the Services sector, focusing on stocks such as Cross Country Healthcare, Five Star Quality Care, and Addus Homecare Corp.

Currently, the analyst consensus on LHC Group is a Moderate Buy with an average price target of $108.50.

See today’s analyst top recommended stocks >>

The company has a one-year high of $103.79 and a one-year low of $58.65. Currently, LHC Group has an average volume of 279.9K.

Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts